GBA Presents: RADIO SAVANT-!

But thanks for your sad face as if you owned it! lol. Paper Trading Tiger you are...

STOCK OF THE DAY ELF BEAUTY.- buy @ $39.00

We ran a blurb on this name a few days ago I'll find it today more positive coverage.
I think beauty plays are going to have a very strong reporting period.--Probably X ray too...
 
--Barclays upgrades Arista to Overweight on sustainable growth 07:51 ANET

--Defense stocks rise as Russia increases Ukraine troop mobilization

AJRD $43.40 <--------- I would stress this name. // Look how we have had all of these straight down days for over a week and still above our purchase price... I told you guys about this name. You'll hate it in a good market.

I do feel we have the possibility here for a fake out. Putin is mobilizing his drunk population for what? To get killed? Putin is going to use nuclear for what? To fight Nato? They will wipe him ff the map.

If you look at these dictators what often happens is escalation right before deal making. The Chinese are famous for this. This could be a way OUT of the War. Right. So defense stocks then would not do well...

China has their big meeting where everyone wil be afraid to say the word Covid so I expect the word Taiwan to be inserted. As in we are waging a war on.... Taiwan. Not Covid... This is truly scary scary stuff. Biden says we will defend Taiwan but does he mean it. Will American Boys and Girls go to war for this country? And would it be for this reason? Lots of questions.

Best thing we could now is get a vbunch of hypersonic weapons into Taiwans hands... AJRD again.
 
vanzandt said:
Yeah.
And had it gapped up to $18 this morning I somehow suspect your post would read a little different.
More...



Absolutely not my friend. My post would be on DICE. Biotechs are like pretty girls... you know when they don't put their makeup on sometimes it's a different story and another one always seems to catch your eye...
 
stonedinvestor said:
But thanks for your sad face as if you owned it! lol. Paper Trading Tiger you are...

STOCK OF THE DAY ELF BEAUTY.- buy @ $39.00

We ran a blurb on this name a few days ago I'll find it today more positive coverage.
I think beauty plays are going to have a very strong reporting period.--Probably X ray too...
More...
Stoney Stoney Stoney...
We got the children in ELF at $27 last summer.
vanzandt said:
I like ELF, NUS, ULTA
These make-up/beauty stocks always hold up well when the markets go down.
The pandemic was the exception.

I just looked at ELF, strong chart. Almost too strong.
More...
 
HOOOOOOOOOWWWWWWWLLLLLLLLLLLL-! $140 PT!

Wolfspeed assumed with a Buy at Canaccord 07:12 WOLF Canaccord analyst George Gianarikas assumed coverage of Wolfspeed with a Buy rating and $140 price target. Wolfspeed is "on the leading edge of the energy systems revolution through its mastery of semiconductor super-material" silicon carbide, or SiC, said Gianarikas, who adds that Wolfspeed has over 30 years of experience in perfecting SiC growth technology and "dominates" the SiC materials market. He views the company's leading share in materials and vertical integration in device development as a key differentiator and long-term competitive advantage, the analyst added.
 
Comstock Resources price target raised to $24 from $17 at Citi 06:23 CRK Citi analyst Paul Diamond raised the firm's price target on Comstock Resources to $24 from $17 and keeps a Buy rating on the shares. The analyst updated his pure-play natural gas small-cap exploration and production models to reflect Citi's revised commodity deck and "improving clarity surrounding the operational landscape into 2023." Diamond says sentiment has improved and that he continues to see "supporting arguments for a persistently strong operating environment in coming quarters." The strip remains in a "strong backwardation" and demonstrates pricing levels more than adequate to provide sufficient free cash flow for the industry's current strategic and capital plans, Diamond tells investors in a research note.

Let me double check 90-% sure there was a recent insider buy here as well....
 
as promised-- Intellia Therapeutics initiated with an Overweight at JPMorgan 06:11 NTLA JPMorgan analyst Brian Cheng initiated coverage of Intellia Therapeutics with an Overweight rating and $85 price target. :wtf:
 
You must log in or register to reply here.
Back
Top